Abstract CT157: Treatment beyond progression with nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck in the phase 3 Checkmate 141 study
Year: 2017
Type: conference-abstract
Source: Cancer Research
Institutions: Dana-Farber/Harvard Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, The University of Texas MD Anderson Cancer Center, Centre Léon Bérard, Centre Antoine Lacassagne, Stanford University, University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori, Essen University Hospital, University of Chicago Medical Center, University of Michigan, Emory University, Winship Cancer Institute, National Cancer Center Hospital East, Bristol-Myers Squibb (United States), Royal Marsden NHS Foundation Trust, Institute of Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2741284897
